Literature DB >> 24345467

Orally active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice.

Kenjiro Matsumoto1, Minoru Narita, Naotaka Muramatsu, Terumi Nakayama, Kaori Misawa, Mariko Kitajima, Kimihito Tashima, Lakshmi A Devi, Tsutomu Suzuki, Hiromitsu Takayama, Syunji Horie.   

Abstract

(E)-Methyl 2-((2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate (7-hydroxymitragynine), a main active constituent of the traditional herbal medicine Mitragyna speciosa, is an indole alkaloid that is structurally different from morphine. 7-Hydroxymitragynine induces a potent antinociceptive effect on mouse acute pain through μ-opioid receptors. In this study, we developed dual-acting μ- and δ-opioid agonists MGM-15 and MGM-16 from 7-hydroxymitragynine for the treatment of acute and chronic pain. MGM-16 showed a higher potency than that of 7-hydroxymitragynine and MGM-15 in in vitro and in vivo assays. MGM-16 exhibited a high affinity for μ- and δ-opioid receptors, with K(i) values of 2.1 and 7.0 nM, respectively. MGM-16 showed μ- and δ-opioid full agonistic effects in a guanosine 5'-O-(3-[(35)S]thiotriphosphate) binding assay and in a functional test using electrically elicited guinea pig ileum and mouse vas deferens contractions. Systemic administration of MGM-16 produced antinociceptive effects in a mouse acute pain model and antiallodynic effects in a chronic pain model. The antinociceptive effect of MGM-16 was approximately 240 times more potent than that of morphine in a mouse tail-flick test, and its antiallodynic effect was approximately 100 times more potent than that of gabapentin in partial sciatic nerve-ligated mice, especially with oral administration. The antinociceptive effect of MGM-16 was completely and partially blocked by the μ-selective antagonist β-funaltrexamine hydrochloride (β-FNA) and by the δ-selective antagonist naltrindole, respectively, in a tail-flick test. The antiallodynic effect of MGM-16 was completely blocked by β-FNA and naltrindole in a neuropathic pain model. These findings suggest that MGM-16 could become a class of a compound with potential therapeutic utility for treating neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24345467      PMCID: PMC6067406          DOI: 10.1124/jpet.113.208108

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  31 in total

1.  A study of kratom eaters in Thailand.

Authors:  S Suwanlert
Journal:  Bull Narc       Date:  1975 Jul-Sep

2.  Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum.

Authors:  Syunji Horie; Fumi Koyama; Hiromitsu Takayama; Hayato Ishikawa; Norio Aimi; Dhavadee Ponglux; Kenjiro Matsumoto; Toshihiko Murayama
Journal:  Planta Med       Date:  2005-03       Impact factor: 3.352

3.  Morphine, gabapentin, or their combination for neuropathic pain.

Authors:  Ian Gilron; Joan M Bailey; Dongsheng Tu; Ronald R Holden; Donald F Weaver; Robyn L Houlden
Journal:  N Engl J Med       Date:  2005-03-31       Impact factor: 91.245

4.  Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa.

Authors:  Kenjiro Matsumoto; Syunji Horie; Hiromitsu Takayama; Hayato Ishikawa; Norio Aimi; Dhavadee Ponglux; Toshihiko Murayama; Kazuo Watanabe
Journal:  Life Sci       Date:  2005-09-15       Impact factor: 5.037

5.  Partial agonistic effect of 9-hydroxycorynantheidine on mu-opioid receptor in the guinea-pig ileum.

Authors:  Kenjiro Matsumoto; Hiromitsu Takayama; Hayato Ishikawa; Norio Aimi; Dhavadee Ponglux; Kazuo Watanabe; Syunji Horie
Journal:  Life Sci       Date:  2005-11-02       Impact factor: 5.037

6.  Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands.

Authors:  Hiromitsu Takayama; Hayato Ishikawa; Mika Kurihara; Mariko Kitajima; Norio Aimi; Dhavadee Ponglux; Fumi Koyama; Kenjiro Matsumoto; Tomoyuki Moriyama; Leonard T Yamamoto; Kazuo Watanabe; Toshihiko Murayama; Syunji Horie
Journal:  J Med Chem       Date:  2002-04-25       Impact factor: 7.446

7.  Nerve injury induces a tonic bilateral mu-opioid receptor-mediated inhibitory effect on mechanical allodynia in mice.

Authors:  Heikki Mansikka; Chengshui Zhao; Rishi N Sheth; Ichiro Sora; George Uhl; Srinivasa N Raja
Journal:  Anesthesiology       Date:  2004-04       Impact factor: 7.892

8.  Inhibitory effect of mitragynine, an analgesic alkaloid from Thai herbal medicine, on neurogenic contraction of the vas deferens.

Authors:  Kenjiro Matsumoto; Leonardo T Yamamoto; Kazuo Watanabe; Shingo Yano; Jie Shan; Peter K T Pang; Dhavadee Ponglux; Hiromitsu Takayama; Syunji Horie
Journal:  Life Sci       Date:  2005-08-16       Impact factor: 5.037

9.  Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa.

Authors:  Kenjiro Matsumoto; Syunji Horie; Hayato Ishikawa; Hiromitsu Takayama; Norio Aimi; Dhavadee Ponglux; Kazuo Watanabe
Journal:  Life Sci       Date:  2004-03-12       Impact factor: 5.037

Review 10.  Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa.

Authors:  Hiromitsu Takayama
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-08       Impact factor: 1.645

View more
  15 in total

1.  Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.

Authors:  Jai Shankar K Yadlapalli; Benjamin M Ford; Amit Ketkar; Anqi Wan; Narasimha R Penthala; Robert L Eoff; Paul L Prather; Maxim Dobretsov; Peter A Crooks
Journal:  Pharmacol Res       Date:  2016-09-13       Impact factor: 7.658

2.  A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.

Authors:  Wei Lei; Rakesh H Vekariya; Subramaniam Ananthan; John M Streicher
Journal:  J Pain       Date:  2019-06-12       Impact factor: 5.820

3.  Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats.

Authors:  Katherine Cone; Janell Lanpher; Abigail Kinens; Philomena Richard; Sarah Couture; Rebecca Brackin; Emily Payne; Kylee Harrington; Kenner C Rice; Glenn W Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2018-03-23       Impact factor: 4.530

4.  Evaluation of Analgesia, Tolerance, and the Mechanism of Action of Morphine-6-O-Sulfate Across Multiple Pain Modalities in Sprague-Dawley Rats.

Authors:  Jai Shankar K Yadlapalli; Navdeep Dogra; Anqi W Walbaum; William D Wessinger; Paul L Prather; Peter A Crooks; Maxim Dobretsov
Journal:  Anesth Analg       Date:  2017-09       Impact factor: 5.108

5.  Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain.

Authors:  Nunzio Vicario; Lorella Pasquinucci; Federica M Spitale; Santina Chiechio; Rita Turnaturi; Filippo Caraci; Daniele Tibullo; Roberto Avola; Rosario Gulino; Rosalba Parenti; Carmela Parenti
Journal:  Mol Neurobiol       Date:  2019-04-28       Impact factor: 5.590

6.  Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.

Authors:  Andrew C Kruegel; Madalee M Gassaway; Abhijeet Kapoor; András Váradi; Susruta Majumdar; Marta Filizola; Jonathan A Javitch; Dalibor Sames
Journal:  J Am Chem Soc       Date:  2016-05-18       Impact factor: 15.419

7.  Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism.

Authors:  Jeffery D Foss; Sunil U Nayak; Christopher S Tallarida; Daniel J Farkas; Sara J Ward; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2020-02-27       Impact factor: 4.492

Review 8.  Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide.

Authors:  Soumen Chakraborty; Susruta Majumdar
Journal:  Biochemistry       Date:  2020-09-22       Impact factor: 3.162

9.  Site selective C-H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy.

Authors:  Srijita Bhowmik; Juraj Galeta; Václav Havel; Melissa Nelson; Abdelfattah Faouzi; Benjamin Bechand; Mike Ansonoff; Tomas Fiala; Amanda Hunkele; Andrew C Kruegel; John E Pintar; Susruta Majumdar; Jonathan A Javitch; Dalibor Sames
Journal:  Nat Commun       Date:  2021-06-22       Impact factor: 14.919

Review 10.  A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans.

Authors:  Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-07-26       Impact factor: 2.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.